Lectins as Antivirals
A special issue of Viruses (ISSN 1999-4915).
Deadline for manuscript submissions: closed (31 August 2016)
Special Issue Information
Dear Colleagues,
Increasingly over the past decade, lectins such as cyanovirin-N, scytovirin and griffithsin have been reported to display antiviral activity against numerous enveloped viruses. Lectins are carbohydrate-binding proteins found in diverse phyla throughout nature. Research into the discovery, the spectrum of antiviral activity, the specific mechanism by which lectins bind their target oligosaccharides on envelope glycoproteins, the structural basis of lectin carbohydrate specificity, the mechanism of lectin antiviral activity and its dependence on both affinity and avidity and the avenues by which viruses can become resistant to lectins, have been pursued by numerous research groups. In addition, the in vivo efficacy of lectins for antiviral therapy and prophylaxis is also an area of continuing research including all aspects of their toxicity, immunogenicity and their large-scale production for clinical utility. The goal of this Special issue is to highlight recent advances in the understanding of lectin antiviral activity and provide updates on the latest research results in this very active area of research.
Dr. Barry R. O'Keefe
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
